|Bid||14.14 x 1000|
|Ask||49.90 x 800|
|Day's range||34.89 - 35.93|
|52-week range||24.35 - 56.43|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||22.03|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Shareholders in Eagle Pharmaceuticals, Inc. ( NASDAQ:EGRX ) may be thrilled to learn that the analysts have just...
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 33.33% and 11.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.